Boasts a Wide Range of ED Medications Hims offers ED medications with three main active ingredients (sildenafil, tadalafil, vardenafil). They are all PDE5 inhibitor medications, which work by ...

Global investment manager Oaktree is out with its third life sciences-dedicated special purpose acquisition company after ...

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission or other tangible benefit. Optum Store, Optum Perks, and Healthline ...

ED is a medical condition in which you regularly have trouble getting or maintaining an arousal firm enough for satisfying ...

Multiple online telehealth companies offer ED medication online. It is important only to use companies offering online consultations with a licensed medical professional. Hims is also a telehealth ...

Despite semaglutide being the active ingredient in Hims & Hers Health Inc’s (NYSE:HIMS) compounded GLP-1 product, a Truist analyst notes that the recent FDA commentary has reignited investor ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our P/B Growth Investor model based on the published ...

Hims, Roman, and Lemonaid all stand out for the ... consultations to receive prescriptions for medications that can treat ED, PE, and other conditions that specifically affect males.

Shares of Hims & Hers Health fell almost 10% today following an announcement from the U.S. Food and Drug Administration (FDA) that competitor Eli Lilly’s obesity and diabetes drugs are no longer ...

Signing a plea agreement that bans hims from the grounds of the University of Virginia and makes him pay court costs, the ...

Hims & Hers Health Q3 2024 revenue projected to surpass estimates by $5M-$10M. Truist consumer survey shows 10% use compounded GLP-1 medications, while 14% prefer branded options. Thursday, The ...